Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Bajorin

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinomaD H Ilson, R J Motzer, R L Kradin, et al.
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.
Melanoma Research|December 1, 1992
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanomaD F Bajorin, P B Chapman, G Y Wong, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
Radiology|May 5, 2000
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapyE W Steyerberg, H J Keizer, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapseF Rabbani, J Sheinfeld, H Farivar-Mohseni, et al.
Cancer|September 15, 1991
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanomaT A Steffens, D F Bajorin, P B Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanomaA A Jakubowski, D F Bajorin, M A Templeton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the hostD J Gallagher, J Vijai, R J Hamilton, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinomaD H Ilson, R J Motzer, R L Kradin, et al.
Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.
Melanoma Research|December 1, 1992
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanomaD F Bajorin, P B Chapman, G Y Wong, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
Radiology|May 5, 2000
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapyE W Steyerberg, H J Keizer, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapseF Rabbani, J Sheinfeld, H Farivar-Mohseni, et al.
Cancer|September 15, 1991
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanomaT A Steffens, D F Bajorin, P B Chapman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanomaA A Jakubowski, D F Bajorin, M A Templeton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the hostD J Gallagher, J Vijai, R J Hamilton, et al.
Pageof 10